1. Home
  2. MRKR vs TOMZ Comparison

MRKR vs TOMZ Comparison

Compare MRKR & TOMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRKR
  • TOMZ
  • Stock Information
  • Founded
  • MRKR N/A
  • TOMZ 1979
  • Country
  • MRKR United States
  • TOMZ United States
  • Employees
  • MRKR N/A
  • TOMZ 26
  • Industry
  • MRKR Biotechnology: Pharmaceutical Preparations
  • TOMZ Diversified Commercial Services
  • Sector
  • MRKR Health Care
  • TOMZ Finance
  • Exchange
  • MRKR Nasdaq
  • TOMZ Nasdaq
  • Market Cap
  • MRKR 21.9M
  • TOMZ 20.2M
  • IPO Year
  • MRKR N/A
  • TOMZ N/A
  • Fundamental
  • Price
  • MRKR $2.16
  • TOMZ $1.01
  • Analyst Decision
  • MRKR Strong Buy
  • TOMZ Strong Buy
  • Analyst Count
  • MRKR 1
  • TOMZ 1
  • Target Price
  • MRKR $19.00
  • TOMZ $3.50
  • AVG Volume (30 Days)
  • MRKR 53.9K
  • TOMZ 327.5K
  • Earning Date
  • MRKR 11-14-2024
  • TOMZ 10-30-2024
  • Dividend Yield
  • MRKR N/A
  • TOMZ N/A
  • EPS Growth
  • MRKR N/A
  • TOMZ N/A
  • EPS
  • MRKR N/A
  • TOMZ N/A
  • Revenue
  • MRKR $5,395,849.00
  • TOMZ $8,197,404.00
  • Revenue This Year
  • MRKR $64.48
  • TOMZ $40.32
  • Revenue Next Year
  • MRKR N/A
  • TOMZ $38.17
  • P/E Ratio
  • MRKR N/A
  • TOMZ N/A
  • Revenue Growth
  • MRKR 79.04
  • TOMZ N/A
  • 52 Week Low
  • MRKR $1.83
  • TOMZ $0.52
  • 52 Week High
  • MRKR $5.99
  • TOMZ $1.50
  • Technical
  • Relative Strength Index (RSI)
  • MRKR 32.84
  • TOMZ 51.69
  • Support Level
  • MRKR $1.83
  • TOMZ $1.01
  • Resistance Level
  • MRKR $2.79
  • TOMZ $1.14
  • Average True Range (ATR)
  • MRKR 0.28
  • TOMZ 0.13
  • MACD
  • MRKR -0.09
  • TOMZ -0.00
  • Stochastic Oscillator
  • MRKR 21.02
  • TOMZ 15.52

About MRKR Marker Therapeutics Inc.

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and innovative peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets. It is also developing peptide-based immunotherapeutic vaccines for the treatment of metastatic solid tumors, as well as PolyStart.

About TOMZ TOMI Environmental Solutions Inc.

TOMI Environmental Solutions Inc is a bacteria decontamination and infectious disease control company, providing environmental solutions for indoor surface decontamination through the manufacturing, sales, service and licensing of its SteraMist brand of products, including SteraMist BIT, a low percentage (7.8%) hydrogen peroxide-based fog or mist that uses Binary Ionization Technology (BIT). Its product portfolio includes SteraMist Surface Unit; SteraMist Environment System; The SteraMist Total Disinfection Cart; SteraMist Select Surface Unit; Stainless Steel 90 Degree Applicator; iHP Plasma Decontamination Chamber; SteraMist Custom Engineered System (CES); and iHP Corporate Service Decontamination.

Share on Social Networks: